FIL Limited Form 8.3 - Allergan Plc (6740M)

TIDMTTM TIDM0Y7T

RNS Number : 6740M

FIL Limited

12 May 2020

Ap19

   FORM   8.3 
   IRISH  TAKEOVER   PANEL 
   DISCLOSURE UNDER RULE 8.3 OF THE IRISH  TAKEOVER   PANEL ACT,  1997,  TAKEOVER  RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

   1.       KEY   INFORMATION 
 
Name of person dealing      FMR LLC and/or one or more 
 (Note 1)                    of its direct or indirect 
                                   subsidiaries 
                                        And 
                              FIL Limited and/or one 
                             or more of its direct and 
                               indirect subsidiaries 
Company dealt in                   ALLERGAN PLC 
                            ========================== 
Class of relevant security       ORDINARY SHARES 
 to which the dealings 
 being disclosed relate 
 (Note 2) 
                            ========================== 
Date of dealing                    11-May-2020 
                            ========================== 
 
   2.         INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant

security   dealt   in   (Note   3) 
 
                                         Long               Short 
                             Number      (%)     Number       (%) 
                             =========  ======  ===========  ====== 
(1) Relevant securities        26,066 0.01% 
                             =================  =================== 
(2) Derivatives (other 
 than options) 
                             =================  =================== 
(3) Options and agreements 
 to purchase/sell 
                             =================  =================== 
Total                          26,066 0.01% 
                             =================  ===================

THE ABOVE INCLUDES A TRANSFER OUT OF 771,611 ORDINARY SHARES.

(b) Interests and short positions in relevant securities of the company, other than the class dealt

  in   (Note   3) 
 
Class of relevant security:                Long                Short 
                              Number        (%)     Number         (%) 
                              =========    ======  ===========    ====== 
(1) Relevant securities 
                              ===================  ===================== 
 
  (2) Derivatives (other 
  than options) 
                              ===================  ===================== 
 
  (3) Options and agreements 
  to purchase/sell 
                              ===================  ===================== 
Total 
                              ===================  =====================

Ap20

   1.       DEALINGS  (Note   4) 
   (a)      Purchases and sales 
 
 Purchase/Sale   Number of relevant securities   Price per unit (Note 5) 
 Sale            934                             193.90 USD/Share 
                ------------------------------  ------------------------ 
 Sale            1,770                           193.94 USD/Share 
                ------------------------------  ------------------------ 
 
   (b)      Derivatives transactions (other than options transactions) 
 
Product    Nature of transaction  Number of relevant   Price per 
 name,      (Note 6)               securities           unit 
 e.g. CFD                          (Note 7)             (Note 5) 
 
 
   (c)      Options transactions in respect of existing relevant securities 
   (i)       Writing,  selling, purchasing or varying 
 
Product     Writing,      Number of       Exercise  Type,            Expiry  Option 
 name,       selling,      securities      price     e.g. American,   date    money paid/received 
 e.g. call   purchasing,   to which                  European                 per unit 
 option      varying       the option                etc.                     (Note 5) 
             etc.          relates (Note 
                           7) 
 
 
   (ii)      Exercising 
 
Product name,             Number of securities      Exercise price 
 e.g. call option                                    per unit (Note 
                                                     5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 
Nature of transaction         Details      Price per unit 
 (Note 8)                                   (if applicable) 
                                            (Note 5)

Ap21

   2.       OTHER  INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any

other person relating to the voting rights of any relevant securities under any option referred to on this

form or relating to the voting rights or future acquisition or disposal of any relevant securities to which

   any derivative referred to on this form is referenced. If none, this should   be   stated. 
   Is a Supplemental Form 8 attached?  (Note   9)                                              NO 
 
Date of disclosure            12-May-2020 
Contact name                  Paul Clark 
                              ================ 
Telephone number              00353 1 223 1447 
                              ================ 
If a connected EFM, name 
 of offeree/offeror with 
 which connected 
                              ================ 
If a connected EFM, state 
 nature of connection (Note 
 10) 
                              ================

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ISEXLLFFBELXBBB

(END) Dow Jones Newswires

May 12, 2020 09:32 ET (13:32 GMT)

Allergan (LSE:0Y7T)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025